Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Connective and Soft Tissue Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Connective and Soft Tissue Neoplasm

Cancer Family

Connective and Soft Tissue Neoplasm

CI-CAN-00000010Explore in graph →

Non-malignant848 active trials17 approved drugs339 evidence items

NCIt: C3810
MeSH: D018204

Overview
Statistics
Survival
Genomics24
Variants & evidence339
Drugs43
Trials3877
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (225)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 126–150 of 225 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.
· Am J Surg Pathol · 2019 · PMID 30720533 · validated civic_curation pubmed
Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.
· Histopathology · 2018 · PMID 29758589 · validated civic_curation pubmed
Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma.
· Genes Chromosomes Cancer · 2024 · PMID 39302072 · validated civic_curation pubmed
Fusion of the Genes WWTR1 and FOSB in Pseudomyogenic Hemangioendothelioma.
· Cancer Genomics Proteomics · 2019 · PMID 31243110 · validated civic_curation pubmed
Gastroblastoma harbors a recurrent somatic MALAT1-GLI1 fusion gene.
· Mod Pathol · 2017 · PMID 28731043 · validated civic_curation pubmed
Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
· Mod Pathol · 2023 · PMID 37422156 · validated civic_curation pubmed
Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
· Cancer Med · 2020 · PMID 32087612 · validated civic_curation

Showing 126–150 of 225 publications

← Previous
1
…
5
6
7
8
9
Next →

The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers.

· Cancer Res · 2010 · PMID 21030459 · validated civic_curation pubmed

Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.

· Cancer Discov · 2014 · PMID 24875859 · validated civic_curation pubmed

The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.

· Int J Cancer · 2016 · PMID 26314551 · validated civic_curation pubmed

Fusion of the EWS and CHOP genes in myxoid liposarcoma.

· Oncogene · 1996 · PMID 8637704 · validated civic_curation pubmed

Fusion events lead to truncation of FOS in epithelioid hemangioma of bone.

· Genes Chromosomes Cancer · 2015 · PMID 26173738 · validated civic_curation pubmed

Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal Tumor.

· Case Rep Oncol · 2011 · PMID 22114577 · validated civic_curation pubmed

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.

· Cancer · 2018 · PMID 30204247 · validated civic_curation pubmed

Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer.

· JCO Precis Oncol · 2018 · PMID 31372595 · validated civic_curation pubmed

A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure.

· Onco Targets Ther · 2018 · PMID 29760553 · validated civic_curation pubmed

Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib.

· Cold Spring Harb Mol Case Stud · 2019 · PMID 30709876 · validated civic_curation pubmed

Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors.

· Int J Surg Pathol · 2020 · PMID 32050835 · validated civic_curation pubmed

Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.

· Hum Mol Genet · 2006 · PMID 16717057 · validated civic_curation pubmed

Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion.

· JCO Precis Oncol · 2022 · PMID 35050712 · validated civic_curation pubmed

Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.

· Mod Pathol · 2018 · PMID 29099503 · validated civic_curation pubmed

Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.

· Ann Oncol · 2019 · PMID 32223937 · validated civic_curation pubmed

Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma.

· Cold Spring Harb Mol Case Stud · 2015 · PMID 27148571 · validated civic_curation pubmed

LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans.

· J Cutan Pathol · 2021 · PMID 32519338 · validated civic_curation pubmed

Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor.

· Clin Sarcoma Res · 2020 · PMID 32782782 · validated civic_curation pubmed